PMDD Treatment with Serotonin Reuptake Inhibitors: Neuroactive Steroids and GABA May Play a Role
A new study from Hantsoo and colleagues asks whether SRI treatment affects the levels of neuroactive steroids modulating GABA-A receptors.
Validated Questionnaire May Improve Identification of Postpartum Women with Childbirth-Associated PTSD
Childbirth-related PTSD is relatively common; routine screening with a survey of PTSD symptoms may identify women in need of specific PTSD interventions.
New Oral Drug Zuranolone (Zurzuvae) for Postpartum Depression is Now Available
The FDA approves zuranolone, a new option for the treatment of PPD, a rapidly acting antidepressant with a good safety profile.
Cannabis Exposure and Adverse Pregnancy Outcomes, Possibility of Placental Insufficiency
In this multicenter cohort, maternal cannabis use documented using urine drug sampling was associated with increased risk of adverse pregnancy outcomes related to placental dysfunction.
Can We use the Electronic Health Record to Predict Risk for Postpartum Depression?
Machine learning can be used to analyze data contained within the electronic health record to accurately predict which individuals are at increased risk for postpartum depression.
Prediction of Postpartum Depression: Take a Closer Look at Question 3 on the PHQ-9
A routinely administered single-item measure of sleep disturbance could identify pregnant individuals who are at risk for PPD and may benefit from depression prevention efforts.
Using Metabolic Biomarkers to Predict Risk for Postpartum Depression
Metabolic biomarkers in the cerebrospinal fluid may be used to identify women at high risk for postpartum depression.
New Oral PPD Treatment Zuranolone Will Soon Hit the Market as Zurzuvae
The FDA approves zuranolone, a new option for the treatment of PPD, a rapidly acting antidepressant with a good safety profile.
Treating Insomnia During Pregnancy: Is Trazodone Safe?
More study is needed regarding the safety of trazodone for the treatment of insomnia during pregnancy.
Pathways to Care for Perinatal Depression: Marked Differences Between Women With and Without Histories of Psychiatric Illness
Compared to individuals with histories of psychiatric illness prior to pregnancy, perinatal individuals without a prepregnancy psychiatric history were less likely to be screened, referred, and treated for depression.